Formation of Hemoglobin Adducts upon Treatment of F344 Rats with the Tobacco-specific Nitrosamines 4-(Methylnitrosamino)-l-(3-pyridyl)-l-butanone and N'-Nitrosonornicotine

Cancer Research

Volumn 47, Issue 10, 1987, Pages 2626-2630

  Carmella, Steven G ^b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b Naylor Dana Institute for Disease Prevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; HEMOGLOBIN; NITROSONORNICOTINE; RADIOISOTOPE; TOBACCO; TOBACCO SMOKE;

4 ( METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; HEMOGLOBINS; MALE; MASS FRAGMENTOGRAPHY; NITROSAMINES; PLANTS, TOXIC; RATS; RATS, INBRED F344; SUPPORT, U.S. GOV'T, P.H.S.; TOBACCO; TRITIUM;

EID: 0023216177     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hoffmann, D., and Hecht, S. S. Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res., 45: 935–944, 1985.
2. Hoffmann, D., Harley, N. H., Fisenne, I., Adams, J. D., and Brunnemann, K. D. Carcinogenic agents in snuff. J. Natl. Cancer Inst., 76:435-437, 1986.
3. Hoffmann, D., Adams, J. D., Brunnemann, K. D., and Hecht, S. S. Assessment of tobacco specific N-nitrosamines in tobacco products. Cancer Res. 39:2505-2509, 1979.
4. Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Publications No. 38, pp. 110–114. Lyon: International Agency for Research on Cancer, 1986.
5. Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Publications No. 38, pp. 163–179. Lyon: International Agency for Research on Cancer, 1986.
6. Hoffmann, D., and Brunnemann, K. D. Endogenous formation of N-nitrosoproline in cigarette smokers. Cancer Res., 43: 5570–5574, 1983.
7. Ladd, K. F., Newmark, H. L., and Archer, M. C. N-Nitrosation of proline in smokers and nonsmokers. J. Natl. Cancer Inst., 73:83-87, 1984.
8. Carcinogenesis 8. Bartsch, H., and Montesano, R. Relevance of nitrosamines to human cancer. (Lond.), 5: 1381–1393, 1984.
9. Tsuda, M., Nütsuma, J., Sato, S., Hirayama, T., Kakizoe, T., and Sugimara, T. Increase in the levels of N-nitrosoproline, N-nitrosothioproline and N-nitroso-2-methylthioproline in human urine by cigarette smoking. Cancer Lett., 30:117-124, 1986.
10. Preussmann, R., and Stewart, R. W. N-Nitroso carcinogens. In: C. E. Searle (ed.), Chemical Carcinogens, Vol. 2, pp. 643–828, ACS Monograph 182, Washington DC: American Chemical Society, 1984.
11. Hecht, S. S., Castonguay, A., Chung, F-L., and Hoffmann, D. Carcinogenicity and metabolic activation of tobacco-specific nitrosamines: current status and future prospects. In: I. K. O'Neill, R. C. Von Borstel, C. T. Miller, J. Long, and H. Bartsch (ed.), N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer. Lyon: International Agency for Research on Cancer Sci. Publ., 57:763-778, 1984.
12. Castonguay, A., Stoner, G. D., Schut, H. A. J., and Hecht, S. S. Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc. Natl. Acad. Sci. USA, 80:6694-6697, 1983.
13. Autrup, H., Jeffrey, A. M., and Harris, C. C. Metabolism of benzo[a]pyrene in cultured human bronchus, trachea, colon, and esophagus. In: A. Bjorseth and A. J. Dennis (eds.), Polynuclear Aromatic Hydrocarbons: Chemistry and Biological Effects, pp. 89–105, Columbus, OH: Battelle Press, 1980.
14. Ehrenberg, L., and Osterman-Golkar, S. Alkylation of macromolecules for detecting mutagenic agents. Teratog. Carcinog. Mutagen., 1:105-127, 1976.
15. Pereira, M. A., and Chang, L. W. Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem.-Biol. Interact., 33:301-305, 1981.
16. Neumann, H-G. Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Arch. Toxicol., 56:1-6, 1984.
17. Tornquist, M., Osterman-Golkar, S., Kautiainen, A., Jensen, S., Farmer, P. B., and Ehrenberg, L. Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis (Lond.), 7: 1519–1521, 1986.
18. Bryant, M. S., Skipper, P. L., Tannenbaum, S. R., and Maclure, M. Hemoglobin adducts of 4-aminobiphenyl in smokers and non-smokers. Cancer Res., 47:602-608, 1987.
19. Hu, M. W., Bondinell, W. E., and Hoffmann, D. Synthesis of carbon-14 labelled myosmine, nornicotine and N'-nitrosonornicotine. J. Labelled Compd., 10:79-88, 1974.
20. Hecht, S. S., and Chen, C. B. Hydrolysis of model compounds for α-hydroxylation of the carcinogens, N-nitrosopyrrolidine and N'-nitrosonor-nicotine. J. Org. Chem., 44: 1563–1566, 1979.
21. Hecht, S. S., Lin, D., and Castonguay, A. Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK). Carcinogenesis (Lond.), 4: 305–310, 1983.
22. Hecht, S. S., Chen, C. B., Dong, M., Ornaf, R. M., Hoffmann, D., and Tso, T. C. Studies on nonvolatile nitrosamines in tobacco. Beitr. Tabakforsch., 9: 1–6, 1977.
23. Hecht, S. S., Lin, D., Chuang, J., and Castonguay, A. Reactions with deoxyguanosine of 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, a model compound for α-hydroxylation of tobacco specific nitrosamines. J. Amer. Chem. Soc., 108:1292-1295, 1986.
24. Hecht, S. S., Young, R., and Chen, C. B. Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-H3-pyridyl)-l-butanone, a tobacco specific carcinogen. Cancer Res., 40:4144-4150, 1980.
25. Hecht, S. S., Rivenson, A., Braley, J., DiBello, J., Adams, J. D., and Hoffmann, D. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res., 46:4162-4166, 1986.
26. hemoglobin. 26. Green, L. C., Skipper, P. L., Turesky, R. J., Bryant, M. S., and Tannenbaum, S. R. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in Cancer Res., 44:4254-4259, 1984.
27. Ringler, D. H., and Dabich, L. Hematology and clinical biochemistry. In: H. J. Baber, J. R. Lindsey, and S. H. Weisbroth (eds.), The Laboratory Rat, Vol. 1, pp. 105–121. New York: Academic Press, 1979.
28. Port, C. J., and Thurnham, D. I. Erythropoiesis and red cell life span in riboflavin-deficient rats. Proc. Nutr. Soc., 42:116A, 1983.
29. Bailey, E., Connors, T. A., Farmer, P. B., Gorf, S. M., and Rickard, J. Methylation of cysteine in hemoglobin following exposure to methylating agents. Cancer Res., 41: 2514–2517, 1981.
30. Osterman-Golkar, S., Ehrenberg, L., Segerback, D., and Hällström, I. Evaluation of genetic risks of alkylating agents. II. Hemoglobin as a dose monitor. Mutat. Res., 34:1-10, 1976.
31. Kim, S., Paik, W. K., Choi, J., Lotlikar, P. D., and Magee, P. N. Microsome-dependent methylation of erythrocyte proteins by dimethylnitrosamine. Carcinogenesis (Lond.), 2:179-182, 1981.
32. Kim, S., Lotlikar, P. D., Chin, W., and Magee, P. N. Proton bound carboxylmethyl ester as a precursor of methanol formation during oxidation of dimethylnitrosamine in vitro. Cancer Lett., 2:279-284, 1977.
33. Chen, C. B., Hecht, S. S., and Hoffmann, D. Metabolic α-hydroxylation of the tobacco specific carcinogen N'-nitrosonornicotine. Cancer Res., 38: 3639–3645, 1978.